DionyMed Brands Inc. (CNSX:DYME) signed a binding term sheet to acquire select MMAC Assets from MM Esperanza 2 LLC for $19 million on March 20, 2019. The definitive agreement was signed on July 19, 2019. Under the term sheet terms of the transaction, Diony Med Brands will acquire all property, leaseholds, equipment and licenses for $13 million in cash, subject to financing and $6 million in Diony Med common shares. The definitive agreement led to the change in the terms, with $13.1 million in cash and $6 million in series A shares. The transaction will be funded with a combination of equity and real estate financing. The completion of the acquisition is subject to several conditions, including, but not limited to the execution and delivery of definitive documentation mutually agreeable to the parties, completion of due diligence on MM Esperanza 2 to the Diony Med Brands sole satisfaction and receipt of all board, shareholder, regulatory and third party approvals for the acquisition. The transaction is expected to close on June 30, 2019. Further to the announcement on July 19, 2019, the closing of the transaction is expected to occur on or before July 23, 2019. DionyMed Brands Inc. (CNSX:DYME) completed the acquisition of select MMAC assets from MM Esperanza 2 LLC on July 24, 2019.